Avicenna Journal of Clinical Microbiology and Infection

Published by: Kowsar

The Correlation Between Biofilm Formation and Drug Resistance in Nosocomial Isolates of Acinetobacter baumannii

Authors Information
1 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University G.C. Tehran, IR Iran
Article Notes and Dates
Avicenna Journal of Clinical Microbiology and Infection: May 2015, 2 (2); e23954.Published Online: May 23, 2015
Article Type: Research Article; Received : September 28, 2014; Revised : December 28, 2014; Accepted : February 3, 2015
DOI: http://dx.doi.org/10.17795/ajcmi-23954

To Cite : Emami S, Eftekhar F. The Correlation Between Biofilm Formation and Drug Resistance in Nosocomial Isolates of Acinetobacter baumannii, Avicenna J Clin Microb Infec. 2015 ;2(2):e23954. doi: 10.17795/ajcmi-23954.

Copyright: Copyright © 0, Avicenna Journal of Clinical Microbiology and Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009; 73(4): 355-63[DOI][PubMed]
  • 2. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21(3): 538-82[DOI][PubMed]
  • 3. Patwardhan RB, Dhakephalkar PK, Niphadkar KB, Chopade BA. A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids. Indian J Med Res. 2008; 128(2): 178-87[PubMed]
  • 4. Jaggi N. Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobial resistance and clinical significance. J Microbiol Infect Dis. 2012; 2(2): 57-63[DOI]
  • 5. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12(9): 826-36[DOI][PubMed]
  • 6. Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros JM, Pachon J, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008; 14(3): 276-8[DOI][PubMed]
  • 7. Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009; 4(3): 273-8[DOI][PubMed]
  • 8. Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litran T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009; 191(19): 5953-63[DOI][PubMed]
  • 9. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res. 2002; 66(2): 86-92[PubMed]
  • 10. Patel R. Biofilms and Antimicrobial Resistance. Clin Orthop Relat Res. 2005; (437): 41-7[DOI]
  • 11. Eftekhar F, Speert DP. Biofilm formation by persistent and non-persistent isolates of Staphylococcus epidermidis from a neonatal intensive care unit. J Hosp Infect. 2009; 71(2): 112-6[DOI][PubMed]
  • 12. Clinical and Laboratory Standards Institute . Performance Standards for Antimicrobial Susceptibility Testing; Approved Standard, M100-S23. 2013;
  • 13. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, et al. Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol. 2005; 23(2): 120-4[PubMed]
  • 14. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol SY, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect. 2008; 14(1): 49-54[DOI][PubMed]
  • 15. Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2008; 26(4): 333-7[PubMed]
  • 16. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35(4): 322-32[DOI][PubMed]
  • 17. Dheepa M, Rashme VL, Appalaraju B. Comparision of biofilm production and multiple drug resistance in clinical isolates of Acinetobacter baumanii from a tertiary care hospital in South India. Int J Pharm Biomed Sci. 2011; 2(4): 103-7
  • 18. Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran. Jundishapur J Microbiol. 2014; 7(1)[DOI][PubMed]
  • 19. Nucleo E, Steffanoni L, Fugazza G, Migliavacca R, Giacobone E, Navarra A, et al. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 2009; 9: 270[DOI][PubMed]
  • 20. Jones RN, Sader HS, Fritsche TR, Rhomberg PR. Carbapenem susceptibility discords among Acinetobacter isolates. Clin Infect Dis. 2006; 42(1): 158[DOI][PubMed]
  • 21. Ikonomidis A, Pournaras S, Maniatis AN, Legakis NJ, Tsakris A. Discordance of meropenem versus imipenem activity against Acinetobacter baumannii. Int J Antimicrob Agents. 2006; 28(4): 376-7[DOI][PubMed]
  • 22. Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, Balikci E, et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit. 2004; 10(6)-4[PubMed]
  • 23. Luzzaro F, Mantengoli E, Perilli M, Lombardi G, Orlandi V, Orsatti A, et al. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol. 2001; 39(5): 1865-70[DOI][PubMed]
  • 24. Revdiwala S, Rajdev BM, Mulla S. Characterization of bacterial etiologic agents of biofilm formation in medical devices in critical care setup. Crit Care Res Pract. 2012; 2012: 945805[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Search Relations:


  • Shiva Emami: [PubMed] [Scholar]
  • Fereshteh Eftekhar: [PubMed] [Scholar]
  • Related Article in PubMed
  • Related Article in Google Scholar

Create Citiaion Alert via Google Reader